Cipla News
Indian Stock Market Closing Report : Banking Stocks Lead The Downfall
Indian Stock Market Closing Report : Banking Stocks Lead The Downfall
istockAnalyst.com - 9 minutes ago
Led by weakness in oil & gas and banking stocks, the Indian markets turned extremely volatile during the final hour of trade today with the benchmark indices closing in the red. On the BSE, there ...
- 19 reads
- Feed: Cipla Pharma News
- Original article
Nifty lingers above 5050; Ranbaxy, Wipro, Cipla up
Nifty lingers above 5050; Ranbaxy, Wipro, Cipla up
Economic Times - 43 minutes ago
MUMBAI: Indian equities were witnessing a choppy session on Wednesday in line with other Asian peers. IT, realty and pharma stocks moved higher while capital goods and oil&gas were subdued. “We ...
- 34 reads
- Feed: Cipla Pharma News
- Original article
H1N1 Virus Drug Supply Offered to USA by Cipla
H1N1 Virus Drug Supply Offered to USA by Cipla
MedIndia - 43 minutes ago
Shortly after securing the permission from World Health Organization and securing the rights to manufacture “Antiflu” to combat H1N1 virus (Swine flu) that has assumed the status of “pan epidemic ...
- 39 reads
- Feed: Cipla Pharma News
- Original article
Cipla launches generic flu drugs
Cipla launches generic flu drugs
Livemint - 4 minutes ago
Mumbai: Drug maker Cipla Ltd on Wednesday launched its generic versions of flu drugs oseltamivir and zanamivir in the local market. These drugs prescribed for the treatment of bird flu as well as ...
- 32 reads
- Feed: Cipla Pharma News
- Original article
Cipla Limited Launches Drug To Treat H1N1 Virus-Reuters
Cipla Limited Launches Drug To Treat H1N1 Virus-Reuters
Reuters Key Development - 7 hours ago
- 42 reads
- Feed: Cipla Pharma News
- Original article
Cipla launches drug to treat Swine flu virus
Cipla launches drug to treat Swine flu virus
NDTV.com - 4 minutes ago
PTI Leading pharmaceutical company, Cipla Ltd has announced the launch of Antiflu to treat H1N1 swine flu virus, a top company official said in Mumbai. "We have launched Oseltamivir brand, called ...
- 52 reads
- Feed: Cipla Pharma News
- Original article
Buy Cipla, target price of Rs 370: Hem Securities
Buy Cipla, target price of Rs 370: Hem Securities
Myiris.com - 7 hours ago
Hem Securities recommends `Buy` on Cipla with a price target of Rs 370 as against the current market price (CMP) of Rs 294.15 (Nov. 9, 2009). ``With the expectation of 10 to 12% growth in revenues ...
- 16 reads
- Feed: Cipla Pharma News
- Original article
Buy Cipla, target Rs 370: Hem Securities
Buy Cipla, target Rs 370: Hem Securities
Myiris.com - 1 hour ago
Hem Securities maintains `Buy` on Cipla with a price target of Rs 370 as against the current market price (CMP) of Rs 294.15 (Nov. 9, 2009). ``The company has registered decent results for the ...
- 40 reads
- Feed: Cipla Pharma News
- Original article
Emergency Contraceptive Pill Ads Face Govt Restriction
Emergency Contraceptive Pill Ads Face Govt Restriction
india-server.com - 50 minutes ago
Even though government has given the green signal for the over-the-counter sales of emergency contraceptive drugs like Cipla's I-pill and Mankind Pharma's Unwanted-72, it said these manufacturer ...
- 48 reads
- Feed: Cipla Pharma News
- Original article
Morning-after pill ads face govt curbs
Morning-after pill ads face govt curbs
Times of India - 53 minutes ago
NEW DELHI: Emergency contraceptive (EC) pills like Cipla's I-pill and Mankind Pharma's Unwanted-72 will continue to be sold over the counter at pharmacy stores, but there will be certain ...
- 32 reads
- Feed: Cipla Pharma News
- Original article
